Literature DB >> 20621195

Remodelling of the human vitreous and vitreoretinal interface--a dynamic process.

Theodorus L Ponsioen1, Johanna M M Hooymans, Leonoor I Los.   

Abstract

The highly hydrated, almost acellular vitreous body of the human eye consists of only 0.1% macromolecules, of which collagens are the most important for its matrix structure. During embryological development, the human vitreous body is a highly dynamic matrix, in which the primary (vascular) vitreous is gradually replaced by the secondary (avascular) vitreous. With aging, the human vitreous undergoes a slowly progressive remodelling, characterized by the gradual formation of collagenous condensations and liquefied spaces in the gel structure. The former is probably the result of collagen synthesis and the deposition of newly formed collagen into the matrix, while the latter is probably due to collagen breakdown. Therefore, remodelling of the vitreous matrix starts at a very early age and continues into old age, albeit at a slower pace. Older theories and concepts of a strict spatial separation between the primary and secondary vitreous during embryonic development, and morphological changes in the aging vitreous being due to a simple aggregation of collagen fibrils are questioned. This review describes the embryological and postnatal remodelling of the human vitreous matrix and vitreoretinal interface, in addition to the mechanisms and cells that are potentially involved in this process.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20621195     DOI: 10.1016/j.preteyeres.2010.07.001

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  15 in total

1.  Novel VCAN mutations and evidence for unbalanced alternative splicing in the pathogenesis of Wagner syndrome.

Authors:  Barbara Kloeckener-Gruissem; John Neidhardt; István Magyar; Henri Plauchu; Jean-Christophe Zech; Laurette Morlé; Sheila M Palmer-Smith; Moira J Macdonald; Véronique Nas; Andrew E Fry; Wolfgang Berger
Journal:  Eur J Hum Genet       Date:  2012-06-27       Impact factor: 4.246

2.  Oral fluoroquinolones and the incidence of rhegmatogenous retinal detachment and symptomatic retinal breaks: a population-based study.

Authors:  Kapil G Kapoor; David O Hodge; Jennifer L St Sauver; Andrew J Barkmeier
Journal:  Ophthalmology       Date:  2014-01-28       Impact factor: 12.079

3.  Quantitative imaging of enzymatic vitreolysis-induced fiber remodeling.

Authors:  Benjamen A Filas; Nihar S Shah; Qianru Zhang; Ying-Bo Shui; Spencer P Lake; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-12-02       Impact factor: 4.799

Review 4.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2021-10-18       Impact factor: 1.779

5.  Is pseudoexfoliation syndrome associated with vitreoretinal interface abnormalities?

Authors:  Seda Karaca Adıyeke; Neslisah Kutlu; Kıvanç Özen; Mehmet Ali Doran; Kemal Demirbaş; Gamze Ture; Ekrem Talay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-08-18       Impact factor: 3.117

6.  Vitreous function and intervention of it with vitrectomy and other modalities.

Authors:  Yao Zong; Qian-Ying Gao; Yan-Nian Hui
Journal:  Int J Ophthalmol       Date:  2022-06-18       Impact factor: 1.645

7.  Pars plana vitrectomy for disturbing primary vitreous floaters: clinical outcome and patient satisfaction.

Authors:  Karlijn F de Nie; N Crama; Maurits A D Tilanus; B Jeroen Klevering; Camiel J F Boon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

8.  Flashes, floaters, and oral fluoroquinolones: is retinal detachment a worry?

Authors:  Dennis P Han; Aniko Szabo
Journal:  JAMA Ophthalmol       Date:  2013-01       Impact factor: 7.389

9.  Enzymatic degradation identifies components responsible for the structural properties of the vitreous body.

Authors:  Benjamen A Filas; Qianru Zhang; Ruth J Okamoto; Ying-Bo Shui; David C Beebe
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-01-03       Impact factor: 4.799

10.  Spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal interface pathologies.

Authors:  Yoreh Barak; Mark A Ihnen; Shlomit Schaal
Journal:  J Ophthalmol       Date:  2012-06-04       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.